Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Operating Expenses (2009 - 2026)

Updated

Vistagen Therapeutics' Operating Expenses came in at $11.08 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 45.5% from $20.31 million a year earlier and down 25.3% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Operating Expenses (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Vistagen Therapeutics reported Operating Expenses of $62.93 million, down 4.9% year-over-year; for FY2026 (ended Mar 31, 2026), it was $73.4 million, up 30.0% from FY2025.

  • Operating Expenses carries a five-year compound annual growth rate of 31.0% (FY2021 to FY2026).
  • Going back by fiscal year, Operating Expenses was $56.46 million in FY2025 (+65.6%), $34.09 million in FY2024 (-42.3%), $59.04 million in FY2023 (+20.8%) and $48.89 million in FY2022 (+157.0%).
  • The fiscal Q2 2027 figure represents the lowest quarterly Operating Expenses since fiscal Q3 2024.
  • Year-over-year, Operating Expenses increased in six of the last eight quarters, with growth averaging 22.2%.
  • The fastest year-over-year change in Operating Expenses over five years came in fiscal Q4 2022 (growth of 151.2%), and the weakest in fiscal Q1 2024 (a decline of 64.3%).
  • Business Quant data shows VTGN's Operating Expenses at $14.82 million (Q1 2027), $17.18 million (Q4 2026) and $19.85 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 2.13 Mn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 15.99 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 11.12 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 11.14 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 12.53 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 6.66 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 4.84 Bn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 11.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.08 Mn
Jun 30, 2026 14.82 Mn
Mar 31, 2026 17.18 Mn
Dec 31, 2025 19.85 Mn
Sep 30, 2025 20.31 Mn
Jun 30, 2025 16.05 Mn
Mar 31, 2025 14.48 Mn
Dec 31, 2024 15.35 Mn
Sep 30, 2024 14.41 Mn
Jun 30, 2024 12.22 Mn
Mar 31, 2024 11.56 Mn
Dec 31, 2023 8.30 Mn
Sep 30, 2023 7.06 Mn
Jun 30, 2023 7.18 Mn
Mar 31, 2023 12.42 Mn
Dec 31, 2022 9.95 Mn
Sep 30, 2022 16.60 Mn
Jun 30, 2022 20.08 Mn
Mar 31, 2022 16.73 Mn
Dec 31, 2021 10.90 Mn
API Access

Vistagen Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY